175 related articles for article (PubMed ID: 17457005)
1. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.
Suzuki S; Yamashita T; Kato T; Fujino T; Sagara K; Sawada H; Aizawa T; Fu LT
Circ J; 2007 May; 71(5):761-5. PubMed ID: 17457005
[TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation.
Kang F; Ma Y; Cai A; Cheng X; Liu P; Kuang J; Mai Z; Mai W
Am J Cardiol; 2021 Mar; 142():74-82. PubMed ID: 33307015
[TBL] [Abstract][Full Text] [Related]
3. Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: a J-RHYTHM Registry analysis.
Yamashita T; Inoue H; Okumura K; Atarashi H; Origasa H;
J Cardiol; 2015 Mar; 65(3):175-7. PubMed ID: 25169015
[TBL] [Abstract][Full Text] [Related]
4. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
Hirano T; Kaneko H; Mishina S; Wang F; Morita S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
7. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.
Inoue H; Okumura K; Atarashi H; Yamashita T; Origasa H; Kumagai N; Sakurai M; Kawamura Y; Kubota I; Matsumoto K; Kaneko Y; Ogawa S; Aizawa Y; Chinushi M; Kodama I; Watanabe E; Koretsune Y; Okuyama Y; Shimizu A; Igawa O; Bando S; Fukatani M; Saikawa T; Chishaki A;
Circ J; 2013; 77(9):2264-70. PubMed ID: 23708863
[TBL] [Abstract][Full Text] [Related]
8. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.
Yamaguchi T
Stroke; 2000 Apr; 31(4):817-21. PubMed ID: 10753981
[TBL] [Abstract][Full Text] [Related]
9. Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation.
Yamashita T; Koretsune Y; Yasaka M; Inoue H; Kawai Y; Yamaguchi T; Uchiyama S; Matsumoto M; Ogawa S
Circ J; 2012; 76(8):1840-7. PubMed ID: 22664798
[TBL] [Abstract][Full Text] [Related]
10. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
Yasaka M; Minematsu K; Yamaguchi T
Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
[TBL] [Abstract][Full Text] [Related]
11. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis.
Koretsune Y; Yamashita T; Yasaka M; Ono Y; Hirakawa T; Ishida K; Kuroki D; Sumida T; Urushihara H
J Cardiol; 2019 Mar; 73(3):204-209. PubMed ID: 30477926
[TBL] [Abstract][Full Text] [Related]
13. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
[TBL] [Abstract][Full Text] [Related]
14. Impact of non-vitamin k antagonist oral anticoagulants on intracranial bleeding in Asian patients with non-valvular atrial fibrillation.
Yasaka M; Lip GY
Circ J; 2014; 78(10):2367-72. PubMed ID: 25213003
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation.
Lee HF; Chan YH; Tu HT; Kuo CT; Yeh YH; Chang SH; Wu LS; See LC
Int J Cardiol; 2018 Jun; 261():78-83. PubMed ID: 29559181
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation.
Coleman CI; Thompson S; Ashton V; Palladino M; Bunz TJ
J Natl Med Assoc; 2020 Aug; 112(4):395-401. PubMed ID: 32493618
[TBL] [Abstract][Full Text] [Related]
17. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Gulløv AL; Koefoed BG; Petersen P
Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
Naganuma M; Shiga T; Sato K; Murasaki K; Hashiguchi M; Mochizuki M; Hagiwara N
Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
[TBL] [Abstract][Full Text] [Related]
19. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
20. INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.
Chung JE; Choi YR; Seong JM; La HO; Gwak HS
Int J Clin Pharm; 2015 Dec; 37(6):1038-46. PubMed ID: 26068570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]